Christopher E. Kubasik - 29 Jul 2025 Form 4 Insider Report for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
29 Jul 2025, 20:35:15 UTC
Prior SEC filing
13 Jun 2025
Next SEC filing
12 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik

Key filing fact

Christopher E. Kubasik filed Form 4 for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX) on 29 Jul 2025.

Key facts

  • This page summarizes Christopher E. Kubasik's Form 4 filing for L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 29 Jul 2025, 20:35.

Change

  • Previous filing in this sequence was filed on 13 Jun 2025.
  • Current net transaction value: -$8,771,760.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001194001 Primary reporting owner

KUBASIK CHRISTOPHER E

Relationship
Chair and CEO, Director
Address
C/O L3HARRIS TECHNOLOGIES, INC., 1025 W. NASA BOULEVARD, MELBOURNE
Signature
By: /s/ John C. Scarborough, Jr., Attorney-in-Fact For: Christopher E. Kubasik
Signature date
29 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LHX transaction

Common Stock, Par Value $1.00

Options Exercise

Transaction value
$10,750,320
Shares
+72,000
Change %
+49%
Price
$149.31
Shares after
217,578
Date
29 Jul 2025
Ownership
Direct
Footnotes
F1
LHX transaction

Common Stock, Par Value $1.00

Sale

Transaction value
$19,522,080
Shares
-72,000
Change %
-33%
Price
$271.14
Shares after
145,578
Date
29 Jul 2025
Ownership
Direct
Footnotes
F2
LHX holding

Common Stock, Par Value $1.00

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,000
Date
29 Jul 2025
Ownership
By grantor retained annuity trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LHX transaction Derivative

Non-Qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-72,000
Change %
-64%
Price
$0.000000
Shares after
40,138
Date
29 Jul 2025
Ownership
Direct
Underlying class
Common Stock, Par Value $1.00
Underlying amount
72,000
Exercise price
$149.31
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Includes 5.37 shares acquired through the Issuer's retirement plan based on information provided by the plan's administrators as of 6/27/2025.

Footnote F2

Reflects the weighted average sale price (prices actually received ranged from $269.92 to $272.31). The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .